secwatch.observer — SEC 8-K summary
======================================

Issuer:     MiNK Therapeutics, Inc. (INKT)
CIK:        0001840229
Form:       8-K
Filed at:   2024-02-29T23:59:59+00:00
Accession:  0000950170-24-023061
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

MiNK receives Nasdaq deficiency notices for MVLS and minimum bid price; faces potential delisting
--------------------------------------------------------------------------------

- On Feb 23, 2024, Nasdaq notified MiNK that its MVLS was below $35M for 30 consecutive days; compliance deadline Aug 21, 2024.
- On Feb 26, 2024, Nasdaq notified MiNK that its common stock bid price closed below $1.00 for 30 consecutive days; deadline Aug 26, 2024.
- To regain MVLS compliance, MVLS must be ≥$35M for 10 consecutive days; failure may lead to delisting with appeal rights.
- To regain bid price compliance, stock must close at ≥$1.00 for 10 consecutive days; possible additional 180-day cure period if eligible.
- MiNK is evaluating options to regain compliance but provides no assurance of success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840229/000095017024023061/0000950170-24-023061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840229/000095017024023061/inkt-20240223.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-023061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer